Journal of Aerosol Medicine and Pulmonary Drug Delivery

Papers
(The H4-Index of Journal of Aerosol Medicine and Pulmonary Drug Delivery is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Breathing Is Enough: For the Spread of Influenza Virus and SARS-CoV-2 by Breathing Only126
Global Burden of Chronic Respiratory Diseases90
Deposition Mechanisms81
Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine71
Naringenin-Loaded Dipalmitoylphosphatidylcholine Phytosome Dry Powders for Inhaled Treatment of Acute Lung Injury28
Nebulized Mesenchymal Stem Cell Derived Conditioned Medium Retains Antibacterial Properties Against Clinical Pathogen Isolates27
Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Stat25
Particle Size Distributions22
Olfactory Targeting of Microparticles Through Inhalation and Bi-directional Airflow: Effect of Particle Size and Nasal Anatomy21
Inhalable Hydroxychloroquine Powders for Potential Treatment of COVID-1916
Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children16
Effectiveness of the Nanosilver/TiO2-Chitosan Antiviral Filter on the Removal of Viral Aerosols14
Fine Particle Fraction: The Good and the Bad14
Realizing Lobe-Specific Aerosol Targeting in a 3D-Printed In Vitro Lung Model14
0.034647941589355